Poster Reception News Today

/PRNewswire/ -- Precision Biologics, a clinical stage therapeutics company whose proprietary platform has produced highly targeted monoclonal antibodies, will...

Global leaders will gather at the annual MDA Clinical & Scientific Conference March 3-6, 2024. Presentations will be held in-person in Orlando, Florida and...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the upcoming poster presentation of new preclinical data for its lead therapeutic candidate, NTX-0250, which ta...